1. Saghafi Khadem S, Sookhtanloo M, Zeidabadi F, Javan Rashid A. Evaluation of High-Sensitivity C-Reactive Protein and Irisin in Saliva and Serum of Patients with Myocardial Infarction. J Mashhad Dental School. 2023;47(2):135-46. DOI: 10.22038/jmds.2023.62712.2134
2. Bogart M, Stanford RH, Laliberté F, Germain G, Wu JW, Duh MS. Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population. Int J Chron Obstruct Pulmon Dis. 2019;14:343-352. PMID: 30863037 DOI: 10.2147/COPD.S184653
3. Melzer AC, Ghassemieh BJ, Gillespie SE, Lindenauer PK, McBurnie MA, Mularski RA, et al. Patient characteristics associated with poor inhaler technique among a cohort of patients with COPD. Respir Med. 2017;123:124-30. PMID: 28137488 DOI: 10.1016/j.rmed.2016.12.011
4. Maricoto T, Santos D, Carvalho C, Teles I, Correia-de-Sousa J, Taborda-Barata L. Assessment of poor inhaler technique in older patients with asthma or COPD: a predictive tool for clinical risk and inhaler performance. Drugs & Aging. 2020;37:605-616. PMID: 32602039 DOI: 10.1007/s40266-020-00779-6
5. Hioki H, Watanabe Y, Kozuma K, Yamamoto M, Naganuma T, Araki M, et al. Effect of serum C-reactive protein level on admission to predict mortality after transcatheter aortic valve implantation. Am J Cardiol. 2018;122(2):294-301. PMID: 29735216 DOI: 10.1016/j.amjcard.2018.04.005
6. Bhattarai A, Shakya R, Bista D. Impact of Pharmacist-Led Intervention on Adherence to Inhalers, Inhalation Technique, and Disease Control Among Asthma/COPD Patients in a Resource Limited Center: An Interventional Study. Patient Prefer Adherence. 2024;18:1395-1408. PMID: 38974680 DOI: 10.2147/PPA.S460810
7. Wen W-H, Cheng M-H, Lee K-C, Lin P-C. Rate of Correct Inhaler Usage and Related Factors in Elderly Patients With Chronic Obstructive Pulmonary Disease. Hu Li Za Zhi. 2024;71(3):43-51. PMID: 38817136 DOI: 10.6224/JN.202406_71(3).07
8. Corsonello A, Pedone C, Battaglia S, Paglino G, Bellia V, Incalzi RA. C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) as inflammation markers in elderly patients with stable chronic obstructive pulmonary disease (COPD). Arch gerontol geriatri. 2011;53(2):190-195. PMID: 21074870 DOI: 10.1016/j.archger.2010.10.015
9. Broekhuizen R, Wouters EF, Creutzberg EC, Schols AM. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax. 2006;61(1):17-22. PMID: 16055618 DOI: 10.1136/thx.2005.041996
10. Silva DR, Gazzana MB, Knorst MM. C-reactive protein levels in stable COPD patients: a case-control study. Int J Chron Obstruct Pulmon Dis. 2015;10:1719-1725. PMID: 26357470 DOI: 10.2147/COPD.S87015
11. Eagan T, Ueland T, Wagner P, Hardie J, Mollnes T, Damås J, et al. Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study. Eur Respir J. 2010;35(3):540-548. PMID: 19643942 DOI: 10.1183/09031936.00088209
12. Kanwal A, Bashir A, Gohier A, Habib B. Association of red blood cell indices and erythrocyte sedimentation rate in chronic obstructive pulmonary disease (copd) patients. Pakistan Armed Forces Med J. 2021;71(2):610-613. Link
13. Fattouh M, Alkady O. Inflammatory biomarkers in chronic obstructive pulmonary disease. Egyptian J Chest Dis Tuberculosis. 2014;63(4):799-804.
14. Leuzzi G, Galeone C, Taverna F, Suatoni P, Morelli D, Pastorino U. C-reactive protein level predicts mortality in COPD: a systematic review and meta-analysis. Eur Respir Rev. 2017;26(143). PMID: 28143876 DOI: 10.1183/16000617.0070-2016